VAXXAS
Vaxxas Pty Ltd
Trademark Registered: 2021-07-13
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79287747 |
| Registration Number | 6413534 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2020-04-20 | Application Filed |
| 2020-06-18 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2020-06-18 | Status: Live/Pending |
| 2020-06-20 | Transaction Date |
| 2021-07-13 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Vaxxas Pty Ltd |
| Address | c/- One Ventures Management, Suite 13.02,; 179 Elizabeth St; Sydney N XP |
| Legal Entity Type | |
| Legal Entity State | XP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 40 |
| U.S. Codes: | 100,103,106 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| International Codes: | 45 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical, medicinal and therapeutic preparations for human and veterinary use; vaccines; vaccine preparations; diagnostic preparations for medical or veterinary purposes; biological substances for human medical diagnostics and analysis; transdermal patches, bandages, poultices and dressings; patches, bandages, poultices and dressings impregnated with vaccines; transdermal vaccine delivery system being patches for administering vaccines; pharmaceutical preparations contained in transdermal patches; skin patches for the transdermal delivery of pharmaceuticals; transdermal patches for administering pharmaceuticals and vaccines; intradermal patches for medical treatment; intradermal vaccine delivery system being patches for administering vaccines; pharmaceutical preparations contained in intradermal patches for medical treatment; skin patches for the intradermal delivery of pharmaceuticals; intradermal patches for medical treatment for administering pharmaceuticals and vaccines; micro-projection array patches for medical purposes; parts, fittings and accessories for the aforesaid goods |
| GS0051 | Pharmaceutical, medicinal and therapeutic preparations for human and veterinary use for the treatment of infectious disease, allergies and oncology; vaccines; vaccine preparations; diagnostic preparations for medical or veterinary purposes; biological specimens, blood and plasma for human medical diagnostics and analysis; transdermal patches, bandages, poultices and medical dressings impregnated with vaccines; patches, bandages, poultices and medical dressings impregnated with vaccines; transdermal vaccine delivery system being patches for administering vaccines; pharmaceutical preparations for treating infectious disease, allergies and oncology contained in transdermal patches; skin patches for the transdermal delivery of pharmaceuticals for use in the treatment of infectious disease, allergies and oncology; transdermal patches for administering pharmaceuticals for use in the treatment of infectious disease, allergies and oncology and vaccines; intradermal patches for use in the medical treatment of infectious disease, allergies and oncology; intradermal vaccine delivery system being patches for administering vaccines; pharmaceutical preparations contained in intradermal patches for use in the medical treatment of infectious disease, allergies and oncology; skin patches for the intradermal delivery of pharmaceuticals for use in the treatment of infectious disease, allergies and oncology; intradermal patches for medical treatment for administering pharmaceuticals for use in the medical treatment of infectious disease, allergies and oncology and vaccines; micro-projection array patches for medical purposes impregnated with vaccines; structural parts and fittings for the aforesaid goods |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2020-06-18 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-06-20 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2020-06-24 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2020-07-11 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-07-19 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2020-07-20 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2020-08-11 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2020-08-11 | 8 RFCS P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-08-19 | 9 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-08-19 | 10 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-08-20 | 11 TEME I:Incoming Correspondence |
| REFUSAL PROCESSED BY IB | 2020-08-30 | 12 RFNT P: |
| NON-FINAL ACTION WRITTEN | 2020-09-10 | 13 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2020-09-10 | 14 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-09-10 | 15 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-02-23 | 16 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-02-23 | 17 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-02-24 | 18 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2021-03-17 | 19 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2021-03-17 | 20 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2021-03-17 | 21 GNFN O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2021-03-22 | 22 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-03-22 | 23 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-03-23 | 24 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-03-23 | 25 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-04-07 | 26 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2021-04-07 | 27 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2021-04-07 | 28 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2021-04-24 | 29 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2021-04-27 | 30 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-04-27 | 31 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2021-07-13 | 32 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2021-10-13 | 33 FICR P: |
| TEAS SECTION 7 REQUEST RECEIVED | 2021-10-31 | 34 ES7R I:Incoming Correspondence |
| FINAL DISPOSITION PROCESSED | 2021-11-09 | 35 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2021-11-09 | 36 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2021-11-28 | 37 FINO P: |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2022-03-24 | 38 APRE A:Allowance for Publication |
| CORRECTION UNDER SECTION 7 ¿ PROCESSED | 2022-03-25 | 39 COC. O:Outgoing Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2022-03-25 | 40 APRE A:Allowance for Publication |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-08-30 | 41 APRE A:Allowance for Publication |
| CORRECTION UNDER SECTION 7 ¿ PROCESSED | 2023-09-05 | 42 COC. O:Outgoing Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-09-05 | 43 APRE A:Allowance for Publication |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 